Thomas Hitchcock, PhD. is the Chief Science Officer for Crown Laboratories, where he oversees clinical development, medical affairs, biological sciences, product development, and research and development for the privately held, fully integrated global company dedicated to developing and providing a diverse portfolio of safe and effective scientific solutions for life-long healthy skin. Dr. Hitchcock is a formally trained scientist with expertise in molecular genetics, microbiology, and dermatology. He has 20+ years of research experience, including basic science, preclinical, and clinical research across several therapeutic areas. He has also been issued patents on his inventions in aesthetic medicine, dermatology, and microbiology. Dr. Hitchcock lectures and presents his research internationally. His work has been published in notable journals such as the “Journal of Biological Chemistry,” “Annals of the New York Academy of Sciences,” “Clinics in Plastic Surgery and Nature,” “Journal of Cosmetic Dermatology,” “Aesthetics Surgery Journal,” “Nucleic Acid Research,” and “Cell Transplantation.”